GConferenceGridThe Conference Catalogue · Vol. 2027Folio № 7B24B4
Healthcare & Medical

LSX Investival Showcase USA 2027

I

nvestival Showcase USA is North America's premier biotech, medtech, and digital health networking event, connecting life science and healthcare innovators with investors and partners through exclusive 1:1 sessions. Building on a decade of European success, this event brings a dynamic partnering format stateside. Attendees include startups, investors, and in…

Visit the official site
12Voices
11Underwriters
0Exhibitors
10On the bill · sessions
23Companies · in total
§I

The Voices

Programmed at LSX, in alphabetical order.
Andrew Lam
Managing Director, Head, Biotech Private Equity · Ally Bridge Group
Anna Argo
Chief Business Officer · Cytotheryx
Elena Itskovich
Founding General Partner · Nest Catalyst Ventures
Hal Paz
Operating Partner · Khosla Ventures
Heather Turner
CEO & Director · LB Pharmaceuticals
Jamil Beg
Partner · SV Health Investors
Jessica Federer
Investor & Board Member · Angelini Ventures
Katerina Fialkovskaya
Investment Director · Philips Ventures
Michael Aberman
General Partner · Regeneron Ventures
Renée Aguiar-Lucander
CEO · Hansa Biopharma
Stella Vnook
Executive Chair & Founder · Kaida & Oral Biolife
Suguna Rachakonda
VP, Business Development · Insilico Medicine
§II

Underwritten By

The houses behind the program. Tiers as disclosed.
Nu-Life SolutionsPlatinum
Brown RudnickGold
MintzGold
Triple Ring TechnologiesGold
Ellenoff Grossman & ScholeSilver
FinneganSilver
Lowenstein Sandler LLPSilver
1004 Venture Partners
AAA Family Office
Melior Capital Management
Neuvation Ventures
§III

The Programme

Selected from 10 sessions on the bill.
  • 10:30am - 11:15am

    South Florida - The Rising Life Science Hub

    South Florida is solidifying its position as a national healthcare and life sciences hub. With its strategic location, growing infrastructure, and influx of investment, the city is…

    Headliner Stage
  • 11:15am - 12:00pm

    How to Get Funded as a Medtech Startup

    - Crafting a compelling value proposition that resonates with investors - Understanding the unique funding challenges in the medtech sector - Preparing for regulatory hurdles that …

    Medtech & Digital Health Stage
  • 11:15am - 12:00pm

    Strategic IP: Maximizing the Value of Your Most Precious Assets

    Is your company’s intellectual property pieces of paper you pray never get a close look, or is it the true crown jewel of your business? This masterclass will address how biotechno…

    Headliner Stage
  • 12:00pm - 12:45pm

    Strategic Considerations for Global Expansion for Life Science Startups

    - Which markets are currently most desirable for startups and why? - Navigating varied and complex regulatory requirements across China, Europe, and the Middle East - Discussing th…

    Headliner Stage
  • 1:45pm - 2:30pm

    Women’s Health - The Trillion Dollar Opportunity

    - Overview of the growth we’ve seen in the space in recent years - Highlighting breakthroughs in diagnostics, therapeutics, and digital health solutions tailored to women’s needs -…

    Headliner Stage
  • 2:30pm - 3:15pm

    TechBio – The Science, Investment & Business Models

    - How do we define TechBio? - Strategies for securing investment in a competitive and evolving market - Discussing the key metrics that define ROI in TechBio - Identify what sets s…

    Headliner Stage
  • 3:15pm - 4:00pm

    The Path to Public: Mastering Your Exit Strategy

    - How to adapt exit strategies in a cautious and unpredictable financial landscape - Beyond the IPO - exploring alternative pathways to liquidity that are gaining traction in today…

    Headliner Stage
  • 4:30pm - 5:15pm

    Fuelling Innovation: The Role of Corporate Venture Capital in Life Sciences

    As life sciences evolve, corporate venture capital (CVC) is becoming a critical driver of innovation. This panel brings together CVC leaders to share insights into their investment…

    Headliner Stage
  • 9:00am - 9:05am

    LSX Welcome

    Headliner Stage
Intermission
Part the Second · For the Buyer

An audience of 23 companies, parsed from the program.

23 companies in attendance.

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

01Fig. 01 — Composition of the House
0All threespeak · spons · exh
11Sponsoringsponsor only
0Exhibitingexhibitor only
12Speakingspeaker only
02Fig. 02 — The Voices, by Seniority

92% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

  • C-suite325%
  • Founder / Owner542%
  • VP-level18%
  • Director / Head of217%
  • Advisor / Investor18%

Of 12 on the bill · classified by free-text title

03Fig. 03 — The Heaviest in the Room
  1. 011004 Venture PartnersSp
  2. 02AAA Family OfficeSp
  3. 03Brown RudnickSp·G
  4. 04Ellenoff Grossman & ScholeSp·S
  5. 05FinneganSp·S
  6. 06Lowenstein Sandler LLPSp·S
  7. 07Melior Capital ManagementSp
  8. 08MintzSp·G
  9. 09Neuvation VenturesSp
  10. 10Nu-Life SolutionsSp·P
  11. 11Triple Ring TechnologiesSp·G
  12. 12Ally Bridge Group1V
  13. 13Angelini Ventures1V
  14. 14Cytotheryx1V
04Fig. 04 — By Tier
platinum1
9% of 11
gold3
27% of 11
silver3
27% of 11
unspecified4
36% of 11